Abstract To develop new nanoparticle materials possessing antioxidative capacity with improved physical characteristics, we have studied titanium-doped cerium oxide (CeTiO 2 ) nanoparticles. CeTiO 2 nanoparticles had mode diameters in the range of 15-20 nm. These nanoparticles demonstrated catalase activity, and did not promote the activation of hemolytic or cytolytic pathways in living cells. Using surface plasmon resonance-enhanced microscopy, we find that these nanoparticles associate with cells. Transmission electron microscopy studies demonstrated that these nanoparticles accumulate within the vacuolar compartment of cells. Importantly, CeTiO 2 nanoparticles decrease hydrogen peroxide-mediated apoptosis of cells as judged by the reduced cleavage of a caspase 3-sensitive label. CeTiO 2 nanoparticles may contribute to deflecting tissue damage in a broad spectrum of oxidant-mediated diseases, such as macular degeneration and Alzheimer's disease.
Introduction
In contrast to their bulk forms, several nanoparticles have the extraordinary ability to carry out chemical transformations traditionally associated with biological enzymes. Included among the enzymologic activities associated with nanoparticles are peroxidase, oxidase, catalase, and superoxide dismutase (Gao et al. 2007 ; Korsvik et al. 2007 ). For example, superoxide dismutase activity has been ascribed to CeO 2 nanoparticles. Moreover, these nanoparticles have been reported to possess antioxidative properties within living cells and animals (Chen et al. 2006; Das et al. 2007; Tarnuzzer et al. 2005; Schubert et al. 2006; Niu et al. 2007; Korsvik et al. 2007; Colon et al. 2009; Elswaifi et al. 2009; Singh et al. 2007) . Thus, catalytic nanoparticles may have a role in deflecting oxidantmediated cell damage in human diseases.
Although catalytic CeO 2 nanoparticles have certain advantages as an experimental therapeutic in replacing or augmenting endogenous antioxidative enzyme activities, they also have limitations. For example, as CeO 2 nanoparticles are crystalline polyhedra (e.g., hexahedral, octahedral, and truncated octahedral), their sharp edges are thought to scratch surfaces during polishing (Feng et al. 2006) . Several studies have shown that nanoparticle toxicity may be traced to nanoparticle shape, with spherical nanoparticles being much less toxic to cells than plate-shaped nanoparticles (George et al. 2012; Pal et al. 2007 ). Thus, nanoparticles bearing flat surfaces may damage both inorganic and biological structures. Furthermore, planar surfaces also contribute to nanoparticle aggregation (Buettner et al. 2010; Keller et al. 2010) . As the superoxide dismutase activity of CeO 2 nanoparticles is greater than that of the biological superoxide dismutase enzyme (Korsvik et al. 2007) , they may reduce superoxide levels below the concentrations required for normal tissue functions. For example, these nanoparticles may interfere with the low levels of superoxide that serve as crucial signaling molecules in cell migration and proliferation (D'Autréaux and Toledano 2007; McCubrey et al. 2006) . Hence, it is of interest to test nanoparticles that exhibit physical and chemical properties better suited for a biological environment.
We have recently reported that Ti-doped CeO 2 nanoparticles exhibit superoxide dismutase activity that is reduced in comparison with nondoped nanoparticles (Zhu and Sun 2012) . We now report that CeTiO 2 nanoparticles possess catalase activity and that this enzymatic activity can reduce hydrogen peroxide-induced apoptosis. The physicochemical and biological properties of these nanoparticles make them an attractive agent for preclinical studies of disease models of oxidant stress.
Materials and methods

Materials
Cell culture media, Hank's balanced salt solution (HBSS), and Calcein-AM were purchased from Invitrogen (Carlsbad, CA, USA). The CaspGLOW red active caspase-3 staining kit was obtained from BioVision (Mountain View, CA, USA). Cover-glass bottom dishes were purchased from MatTek Corporation (Ashland, MA, USA).
Nanoparticles
The compositions of nanoparticles used in these studies were CeO 2 (lot number 6SB232A2), Ce Nanoparticle suspensions Nanoparticles were suspended in HBSS, and maintained at 4°C. All suspensions were vortexed before use.
Cell culture
Tumor cells were maintained on plastic tissue culture flasks in Dulbecco's modified Eagle medium (DMEM, Invitrogen) containing 10 % heat-inactivated FBS (Invitrogen) and 1 % antibiotic/antimycotic (Invitrogen), as previously described (Clark et al. 2010 . Cells were detached using a trypsin/EDTA solution (Invitrogen), transferred to fresh media, and plated onto glass cover slips 24 h before use. For cytolysis assays, cells were plated into 96-well cell culture plates (Costar 3595, Corning Inc., Corning, NY, USA) at 10 4 cells per well in DMEM.
Hemolysis assay
Peripheral blood was collected from healthy human donors in compliance with the guidelines of the University of Michigan Institutional Review Board for Human Subject Research. Red blood cells were isolated using Ficoll-Histopaque (Sigma) density gradient centrifugation, then re-suspended, and washed in HBSS by centrifugation. Cells were treated with nanoparticles for 3 h at 37°C. Cells were centrifuged, and supernatants transferred to a 96-well plate. Absorbance at 540 nm was read on a FlexStation plate reader (Molecular Devices, Sunnyvale, CA, USA). A sample treated with 1 % Triton-X 100 (Sigma) in HBSS was used as a 100 % hemolysis standard.
Cytolysis assay
Cells were labeled with Calcein-AM (Invitrogen) for 30 min at 37°C, and washed thoroughly with HBSS. Triplicate wells were treated with CeTiO 2 nanoparticles at the concentrations indicated below or with 1 % Triton-X 100 in HBSS to serve as a reference sample for 100 % release. The plate was then incubated for 3 h at 37°C. After incubation, supernatants were centrifuged to remove particulates. Supernatants were transferred to a fresh 96-well plate then read on a FlexStation II (Molecular Devices) using an excitation of 494 nm and emission of 517 nm. Fluorescence intensities were averaged over triplicate wells.
Catalase assay
Catalase catalyzes the conversion of hydrogen peroxide to water and molecular oxygen. The Amplex Red catalase assay kit was employed to detect catalase activity (Invitrogen). Experiments were performed as described by the manufacturer. In brief, a solution of 2 mg/ml nanoparticles and 0.02 lM H 2 O 2 in PBS was incubated at room temperature for 30 min with shaking. After removal of nanoparticles by centrifugation, 100 ll of each control or test solution was added to one well of a multiwell plate. To this solution, an equal volume of PBS containing 50 lM Amplex Red and 0.1 U/ml horseradish peroxidase was added. After 30 min, the fluorescence was measured using 530 nm excitation and 590 nm emission. Catalase activity was demonstrated by the disappearance of hydrogen peroxide, as judged by the loss of Amplex Red florescence.
Apoptosis
Cells were seeded into cover-glass bottom dishes and allowed to grow for 24-48 h. CeO 2 or CeTiO 2 nanoparticles were added at the concentrations indicated below and then incubated at 37°C. After 24 h, the plates were washed with HBSS, then incubated for 3 h at 37°C with either HBSS or HBSS containing 200 lM H 2 O 2 . Samples were stained for activated caspase-3 using the CaspGLOW TM red active caspase-3 staining kit (BioVision) as directed by the manufacturer. Plates were washed and then imaged using a Nikon microscope with a 40 9 objective (see below). Caspase-3 red labeling was observed using a Nikon 96321 filter set composed of a 570 nm dichroic mirror, a 530-560 nm excitation filter, and a 590-650 nm emission filter.
Brightfield microscopy Cells were seeded onto cover slips and allowed to grow for 24 h. Cover slips were treated with nanoparticles or buffer alone for an additional 24 h. Cells were washed with HBSS, and then mounted live for microscopy. Cells were observed using a Nikon microscope equipped with an Andor iXon camera (Andor Techol., Belfast, Northern Ireland) attached to the bottom port of a Nikon TE2000-U inverted microscope that incorporated a 100 W mercury lamp for excitation.
Surface plasmon resonance enhanced dark-field microscopy A CytoViva, Inc. (Auburn, AL) darkfield condenser and illumination source were attached to a Zeiss carrier for transmitted light illumination. A Zeiss Axiovert microscope equipped with a 1009 darkfield objective (Olympus) was employed. Surface plasmon resonance-enhanced microscopy produces a very high contrast image of high optical resolution (90 nm). To preserve resolution, a 1.99 Optem camera coupler (Qioptiq Imaging Solutions, Fairport, NY, USA) was used to direct the image to a large format (4,096 9 4,096) Alta-U16 M camera (Apogee Imaging Systems, Roseville, CA, USA). The camera was watercooled to reduce the dark noise and to minimize physical vibrations due to cooling. Images were processed using Metamorph software (Molecular Devices).
Electron microscopy Nanoparticles were studied as whole mounts on carbon-coated copper grids. For cell studies, untreated control cells or nanoparticle-treated cells were fixed in 1 % glutaraldehyde in phosphate-buffered saline for 1 h. Samples were then post-fixed with 1 % osmium tetroxide (Polysciences, Warrington, PA, USA) in cacodylate buffer for 1 h. Cells were dehydrated in an increasing, graded series of ethanol in water. Samples were washed three times in 100 % ethanol and then treated with an increasing series of Spurr's resin and ethanol. After three washes with 100 % resin, the resin was polymerized overnight at 60°C. Thin sections were cut, and then counterstained with lead citrate and uranyl acetate. Transmission electron micrographs were collected using a Philips CM-100 TEM.
Results
Nanoparticles
TEM studies were performed to assess nanoparticle properties. Figuer 1 shows a TEM image of CeTiO 2 nanoparticles. These nanoparticles are spherical in shape and range in size from *5 to *115 nm. Figure 2 shows a plot of the size distribution of the nanoparticles; as shown by this graph; the mode of the distribution was 15-20 nm.
Enzymatic activities
We have recently reported that CeTiO 2 nanoparticles possess catalytic activities mimicking those of the enzymes, superoxide dismutase, and oxidase (Zhu and Sun 2012) . To determine whether CeTiO 2 nanoparticles possess catalase activity, experiments were performed using Amplex Red-based methodology. As catalase removes H 2 O 2 from the solution, less Amplex Red is converted into the highly fluorescent molecule resorufin. Figure 3 shows a series of experiments performed in the presence or absence of nanoparticles. The addition of H 2 O 2 to a reaction mixture in the absence of nanoparticles led to high levels of fluorescence, as anticipated. The addition of WO 3 nanoparticles, which have not been reported to possess catalase activity, were used as a negative control; these nanoparticles had no effect on the fluorescence signal. However, the addition of CeO 2 or CeTiO 2 nanoparticles to reaction mixtures did reduce H 2 O 2 levels thereby decreasing fluorescence, which indicates a catalase-like enzymatic activity. As proteins can bind to nanoparticles and thereby alter their properties (Mahmoudi et al. 2011) , we have tested the effect of cell culture medium on the catalytic activity of CeTiO 2 nanoparticles. Nanoparticles were incubated in culture medium for 48 h at 37°C. The nanoparticles were then transferred to catalase assay medium. In paired experiments with untreated nanoparticles, no significant difference in catalase activity were observed (data not shown), which suggests that the incubation conditions have no catalytic effect on the nanoparticles. Observation of catalytic nanoparticles in vitro After a 24-h growth period on cover slips, cells were cultured with 17 ng/ml CeTiO 2 nanoparticles for an additional day. Cells were then washed with HBSS. To determine if CeTiO 2 nanoparticles became associated with cells, microscopy experiments were performed. Surface plasmon resonance-enhanced darkfield microscopy was employed to detect nanoparticles. Figure 4 shows a surface plasmon resonanceenhanced darkfield micrograph of CeTiO 2 nanoparticle-treated cells. As this high magnification optical micrograph shows, nanoparticles can be found throughout the cytoplasm of the cell, occasionally in clusters. They are, however, not detected in the nucleoplasm of the cell. In contrast, untreated cells did not reveal the presence of intensely scattering nanoparticles (data not shown).
To localize CeTiO 2 nanoparticles to specific intracellular organelles, transmission electron microscopy was performed. Cells were incubated in the presence or the absence of nanoparticles followed by processing for thin section transmission electron microscopy. Figure 5 shows electron micrographs of cells processed without (panel a) and with (panel b) prior treatment with CeTiO 2 nanoparticles. Nanoparticletreated cells exhibit electron dense staining because of nanoparticle accumulation with the cells. The dark nanoparticles are found within the vacuolar apparatus of the cell. The nanoparticles could not be found in other organelles such as the nuclei and mitochondria of cells. In other thin sections (data not shown), CeTiO 2 nanoparticles were found in association with the plasma membrane, suggesting that endocytosis might be a mechanism of cell entry. Hence, these nanoparticles are delivered to specific intracellular regions, and are not randomly dispersed within cells.
Hemolysis and cytotoxicity
We first examined the ability of CeTiO 2 nanoparticles to rupture erythrocyte plasma membranes using hemolysis assays. Human erythrocytes were treated with 1 ng/ml to 10 lg/ml nanoparticles for 3 h at 37°C. Erythrocytes in buffer only were used as negative controls, whereas erythrocytes treated with Triton-X 100 were used to measure 100 % hemolysis. After exposure to CeTiO 2 nanoparticles, no hemolysis could be detected (Fig. 6) . Hence, these catalytic nanoparticles do not appear to influence the integrity of erythrocyte membranes.
Although CeTiO 2 nanoparticles do not promote hemolysis, it is possible that they affect the integrity of nucleated cell membranes. To determine if nanoparticles cause the cytoplasm to leak from cells, they were labeled with the fluorescent marker Calcein-AM. Cells were labeled with Calcein-AM as we have previously described (Clark et al. 2010) , then used in a markerrelease assay. Control cells were treated with buffer alone. Cells were treated with 1 % Triton X100 as a positive control for Calcein release (Fig. 7) . After a 3-h incubation with CeTiO 2 nanoparticles (10 ng/ml to 10 lg/ml), no cytotoxicity was observed (Fig. 7) . This range of concentrations was chosen because it includes biologically relevant activity levels (see below). Hence, these nanoparticles did not display hemolytic and nucleated cell cytolytic activity.
Apoptosis
Having assessed the physical, chemical, and toxicological properties of CeTiO 2 nanoparticles, we next evaluated their ability to protect living cells from H 2 O 2 -mediated apoptosis. In these experiments, caspase-3 activation was measured using the Casp-GLOW TM red active caspase-3 staining kit, which is a Fig. 4 Imaging CeTiO 2 nanoparticles with living cells using surface plasmon enhanced darkfield microscopy. The nanoparticles are observed as bright dots during darkfield microscopy. Note that the nanoparticles can be found in the cytoplasm of the cell, but are excluded from the nucleus (N) (9100 objective) (n = 3) cell membrane-permeable molecule consisting of a fluorogenic dye and a DEVD moiety specific for caspase-3. Samples were incubated with Casp-GLOW TM red active caspase-3 substrate in the dark for 30 min, then washed with HBSS, and observed using fluorescence microscopy. The fluorescence labeling of activated caspase-3 was quantified. After an overnight incubation with CeTiO 2 nanoparticles, cells were treated with H 2 O 2 (200 lM) or buffer for 3 h at 37°C. Cells treated with 200 lM H 2 O 2 in the absence of nanoparticles demonstrate high levels of apoptosis (*50 %) compared to the low levels of apoptosis (*7 %) found for cells treated with buffer alone in the absence of nanoparticles (Fig. 8, first and second columns). CeTiO 2 nanoparticles, which exhibit catalase activity (Fig. 3) , protect cells from H 2 O 2 -induced apoptosis (Fig. 8) . However, in the absence of exogenous H 2 O 2 , nanoparticles had no influence on the level of apoptosis (Fig. 8, third column vs. first  column) . Similarly, CeTiO 2 nanoparticles protected cells from H 2 O 2 -induced changes in cell shape (data not shown). This was anticipated because caspase 3 also cleaves ROCK-1 kinase, which disrupts microfilaments within cells thereby leading to changes in cell shape (Sebbagh et al. 2001; Ndozangue-Touriguine et al. 2008) . Although H 2 O 2 causes a dramatic increase in the percentage of caspase-3 positive cells, this can be significantly reduced by treatment with CeTiO 2 nanoparticles.
Discussion
Due to their unique physical and chemical properties, nanoparticles are assuming a greater role in heterogeneous catalysis. Certain nanoparticle catalysts, such as CeO 2 , CeTiO 2 , and Pt nanoparticles, exhibit the ability to destroy reactive oxygen species (ROS) in aqueous environments (e.g., Chen et al. 2006; Clark et al. 2011; Colon et al. 2009 ). This catalytic activity has attracted interest in the potential clinical utility of these nanoparticles in managing ROS-mediated disorders. Included among these disorders are Alzheimer's disease, diabetic retinopathy, age-related macular degeneration, glaucoma, and amyotrophic lateral sclerosis (Osborn 2008; Kawaji et al. 2011; Wu et al. 1997; Kowluru et al. 2006; Caldwell et al. 2005; Kanwar et al. 2007) . In an effort to develop a new therapeutic nanoparticle to manage ROSmediated disease, we studied CeTiO 2 nanoparticles.
In the present study, we have found that the endogenous catalytic activity of CeTiO 2 nanoparticles was sufficient to largely deflect the activation of cell death pathways induced by H 2 O 2 , a crucial step in many disease processes. One advantage of CeTiO 2 nanoparticles is their spherical shape, as illustrated for Ce 0.875 Ti 0.125 O 2 (Fig. 1) and CeTiO 2 (Zhu and Sun 2012) nanoparticles. As mentioned above, this shape offers improved biocompatibility. Another advantage of CeTiO 2 nanoparticles is that their superoxide dismutase activity is slightly less than that of CeO 2 nanoparticles (Zhu and Sun 2012) . This is because the objective is to reduce, not eliminate, ROS. ROS participate in normal intercellular communication pathways within tissues. Moreover, harmful effects at the cellular level were not found in two assays of cell damage. Finally, the effectiveness of CeTiO 2 nanoparticles in diminishing apoptosis was demonstrated. Hence, these nanoparticles have catalytic and physiological advantages of other nanoparticles for biological use, but with reduced potential to harm cells.
The ability of CeTiO 2 nanoparticles to deflect H 2 O 2 -mediated apoptosis suggests that the nanoparticles have access to exogenous H 2 O 2 . Our electron microscopy studies have shown that CeTiO 2 nanoparticles are primarily found within the intracellular vacuolar system (Fig. 5) . Previous studies have shown that H 2 O 2 enters cells via diffusion (Ohno and Gallin 1985) . Indeed, the exogenous addition of H 2 O 2 can be detected within cells using H 2 O 2 -sensitive probes (e.g., Petty and Francis 1985; Cao et al. 1993) . Hence, intracellular nanoparticles would have access to H 2 O 2 .
The present study demonstrates the concept that CeTiO 2 nanoparticles are capable of reducing H 2 O 2 -mediated apoptosis in tumor cells. However, as cells may differ in their interaction with nanoparticles, the nanoparticles' ability to influence physiological outputs may vary among cell types (Mahmoudi et al. 2012) . Hence, although CeTiO 2 nanoparticles possess catalytic activity, the manifestations of that activity may vary depending upon the specific cellular environment.
Currently, nanoparticles are being used or tested as contrast agents in magnetic resonance imaging, drug delivery vehicles, and mediators of directed hyperthermia. However, catalytic nanoparticles are not being used in patient care, although they have been tested in several animal models of disease. The advantages described above for CeTiO 2 nanoparticles might make them a more attractive candidate for clinical trials. This study suggests that CeTiO 2 nanoparticles will be useful in preclinical studies and, if successful, may lead to a new nanoparticle therapy. To develop a clinically relevant animal model, we are presently studying experimental approaches to deliver these nanoparticles to regions of oxidative damage and to target specific tissues.
